ARCA biopharma, Inc. Skyrocketed

Fri, Sep 06, 2024 at 07:33 PM
ARCA biopharma, Inc. Skyrocketed

ARCA biopharma, Inc. (ABIO:NASDAQ) soared at $28.8, a gain of 1052%. On Fri, Sep 06, 2024, ABIO:NASDAQ touched a New 2-Week Intraday Low of $2.25. The stock appeared on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Fri, Aug 23, 2024, the stock recorded 22.22% Up Days and 80.00% Green Days

About ARCA biopharma, Inc. (ABIO:NASDAQ)

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.